Current Edition


Novartis hits another setback in plan to repurpose rare disease drug in lung cancer

Novartis’ testing of canakinumab, which works by curbing inflammatory signaling in cells, for the seemingly unrelated use in lung cancer stems from an intriguing 2011 …

Continue Reading →

International Conference on Molecular Biology and Stem Cells

The world’s largest Molecular Biology Conference and Stem Cells gathering for the Research Community, Join the Genetics Conference at Copenhagen, Denmark on Aug13-15,2018. Molecular Biology …

Continue Reading →

Blood vessel-forming cells involved in aggressive brain tumour

Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. A type of highly malignant brain …

Continue Reading →